MAMISEAL SUSPENSION INTRAMAMMAIRE POUR BOVINS (VACHES LAITIERES)
MAMISEAL SUSPENSION INTRAMAMMAIRE POUR BOVINS (VACHES LAITIERES)
Not authorised
- Bismuth
Product identification
Medicine name:
MAMISEAL SUSPENSION INTRAMAMMAIRE POUR BOVINS (VACHES LAITIERES)
Active substance:
- Bismuth
Target species:
-
Cattle (cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Bismuth1.86/gram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG52X
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Continental Farmaceutica
Marketing authorisation date:
Manufacturing sites for batch release:
- Cross Vetpharm Group Limited
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Spanish Agency For Medicines And Health Products
Authorisation number:
- 2653 ESP
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0397/001/DC
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 14/03/2026